Core Viewpoint - Visionary Copper and Gold Mines Inc. is initiating a non-brokered private placement to raise up to $3.0 million to fund a drilling campaign at its 100% owned Pt. Leamington Project in Newfoundland [1]. Group 1: Offering Details - The Offering will consist of three components: 1. Up to 1,560,000 hard dollar units (HD Units) priced at C$0.75 each, aiming for gross proceeds of up to C$1,170,000 [2]. 2. Up to 1,333,333 flow-through units (FT Units) priced at C$1.11 each, targeting gross proceeds of up to $1,480,000 [2]. 3. Up to 267,175 Manitoba flow-through units (MB FT Units) priced at C$1.31 each, with gross proceeds of up to $350,000 [2]. Group 2: Unit Composition - Each HD Unit will consist of one common share and one-half of a transferable common share purchase warrant [3]. - Each FT Unit and MB FT Unit will consist of one flow-through common share and one-half of a transferable warrant [3]. Group 3: Use of Proceeds - Gross proceeds from the sale of FT Units will be allocated to eligible "Canadian exploration expenses" related to the Pt. Leamington Project, with all qualifying expenditures renounced in favor of the subscribers effective December 31, 2025 [4]. - Net proceeds from the sale of HD Units will be utilized for working capital and general corporate purposes [4]. Group 4: Company Overview - Visionary Copper and Gold Mines Inc. is focused on advancing its portfolio of base and precious metals deposits in established Canadian mining jurisdictions, particularly the Pt. Leamington Deposit in Newfoundland [7]. - The company has reported an indicated mineral resource of 5.0 million tonnes grading 2.5 g/t AuEq, equating to 402,000 ounces of AuEq [7]. - The company is also permitting the Rainbow deposit at its Pine Bay Project, with an indicated mineral resource of 3.44 million tonnes grading 3.59% CuEq, containing 272.4 million pounds of CuEq [7].

Core Viewpoint - Visionary Copper and Gold Mines Inc. is initiating a non-brokered private placement to raise up to $3.0 million to fund a drilling campaign at its 100% owned Pt. Leamington Project in Newfoundland [1] Offering Details - The Offering will consist of three components: 1. Up to 1,560,000 hard dollar units (HD Units) priced at C$0.75 each, aiming for gross proceeds of up to C$1,170,000 [2] 2. Up to 1,333,333 flow-through units (FT Units) priced at C$1.11 each, targeting gross proceeds of up to $1,480,000 [2] 3. Up to 267,175 Manitoba flow-through units (MB FT Units) priced at C$1.31 each, with gross proceeds of up to $350,000 [2] Unit Composition - Each HD Unit will consist of one common share and one-half of one transferable common share purchase warrant [3] - Each FT Unit and MB FT Unit will consist of one flow-through common share and one-half of one transferable Warrant [3] Use of Proceeds - Gross proceeds from the sale of FT Units will be allocated to eligible "Canadian exploration expenses" related to the Pt. Leamington Project, with all qualifying expenditures renounced in favor of the subscribers effective December 31, 2025 [4] - Net proceeds from the sale of HD Units will be utilized for working capital and general corporate purposes [4] Company Overview - Visionary Copper and Gold Mines Inc. is focused on advancing its portfolio of base and precious metals deposits in established Canadian mining jurisdictions, particularly the Pt. Leamington Deposit in Newfoundland [7] - The company has reported an indicated mineral resource of 5.0 million tonnes grading 2.5 g/t AuEq, equating to 402,000 ounces of AuEq [7] - The company is also permitting the Rainbow deposit at its Pine Bay Project, with significant mineral resources reported [7]

Core Viewpoint - Cymat Technologies Ltd. is conducting a non-brokered private placement of equity Units to raise gross proceeds of $1,551,500, with each Unit priced at $0.13, consisting of one Common Share and one Common Share Purchase Warrant [2][4]. Group 1: Offering Details - The offering will issue 11,934,615 equity Units, with each Warrant allowing the holder to purchase one Common Share at a price of $0.18 for a period of 24 months [2]. - No Company Insiders will participate in this offering, and if the exercise of Warrants creates a new Insider, the Company will rely on an exemption from formal valuation and minority shareholder approval requirements [3]. - The proceeds will be allocated for capital equipment purchases and working capital requirements [4]. Group 2: Company Overview - Cymat Technologies Ltd. holds global rights to manufacture and sell Stabilized Aluminum Foam (SAF), a lightweight, recyclable material used in various industries including architectural design, military, and automotive [5]. - The proprietary production process of SAF involves injecting gases through a molten bath of alloyed aluminum infused with ceramic particles, resulting in a material with customizable density and dimensions, mechanical energy absorption, and thermal and acoustic insulation [5].

Core Points - GRAIL, Inc. has entered into a securities purchase agreement for a private placement expected to yield gross proceeds of approximately $325.0 million before expenses [1][2][4] - The private placement involves participation from both new and existing institutional investors, including notable firms such as Deep Track Capital and Farallon Capital Management [2] - GRAIL plans to utilize the net proceeds for commercial activities, reimbursement efforts, working capital, and general corporate purposes [2][3] Financial Details - GRAIL will issue and sell 4,639,543 shares of common stock at a price of $70.05 per share, with the private placement expected to close on October 21, 2025, pending customary closing conditions [4][5] - The company anticipates that its cash, cash equivalents, and investments, along with the expected net proceeds from this private placement, will fund operations into 2030 [3] Regulatory Information - The securities sold in this private placement have not been registered under the Securities Act of 1933 and may not be offered or sold in the U.S. without an effective registration statement or applicable exemption [6] - GRAIL has granted registration rights to purchasers and will file a registration statement with the SEC for the resale of the shares [6] Company Overview - GRAIL is focused on early cancer detection using next-generation sequencing and advanced machine learning technologies, aiming to alleviate the global burden of cancer [8] - The company is headquartered in Menlo Park, CA, with additional locations in Washington, D.C., North Carolina, and the United Kingdom [8]

Core Viewpoint - STLLR Gold Inc. has successfully closed a private placement financing for total gross proceeds of C$36,613,902, aimed at advancing its Tower Gold and Hollinger Tailings projects in the Timmins Mining Camp [1][8] Financing Details - The financing consists of multiple components, including: - 2,790,200 Premium FT Shares sold at C$1.792 for gross proceeds of C$5,000,038.40 - 3,246,800 FT Shares sold at C$1.54 for gross proceeds of C$5,000,072 - 5,166,026 Hard Dollar Shares sold at C$1.28 for gross proceeds of C$6,612,513.28 - 11,719,000 Best Efforts Shares sold at C$1.28 for gross proceeds of C$15,000,320 - 3,907,000 Concurrent Shares sold at C$1.28 for gross proceeds of C$5,000,960 [2][5] Insider Participation - Certain insiders participated in the offering, which is classified as a "related party transaction" under Multilateral Instrument 61-101 - Eric Sprott increased his ownership to approximately 15% and Agnico Eagle increased its stake to approximately 11% through their participation [2][3] Use of Proceeds - Gross proceeds from the Premium FT Shares and FT Shares will be allocated to Canadian exploration expenses qualifying as flow-through mining expenditures, to be incurred by December 31, 2026 [4] - Net proceeds from Hard Dollar Shares, Best Efforts Shares, and Concurrent Shares will be used for operating expenses and general corporate purposes [5] Company Overview - STLLR Gold Inc. is a Canadian gold development company focused on advancing high-potential gold projects, including the Tower Gold Project and the Hollinger Tailings Project in Ontario, and the Colomac Gold Project in Northwest Territories [8]

Core Points - International Prospect Ventures Ltd. has completed a non-brokered private placement offering for gross proceeds of $602,000 [1][2] - The offering consisted of 12,040,000 Units priced at $0.05 each, with each Unit including one common share and one non-transferable share purchase warrant [2] - The offering was oversubscribed by 40,000 Units, resulting in additional gross proceeds of $2,000 [2] Company Participation and Transactions - Four insiders participated in the offering, contributing a total of $256,000, which is classified as a Related Party Transaction [3] - The company utilized exemptions from formal valuation and minority shareholder approval requirements due to the transaction's fair market value being below $2,500,000 [3] Finder's Fees and Use of Proceeds - The company issued 265,200 common shares at a deemed price of $0.05 to an arm's length party as finder's fees, totaling $13,260 [4] - The net proceeds from the offering will be allocated for general corporate purposes [4] Securities and Hold Period - All securities issued under the offering are subject to a hold period until February 15, 2026, in accordance with applicable securities legislation [5] Company Overview - International Prospect Ventures is a junior mineral exploration company with interests in mining claims primarily located in the Pilbara Craton, Western Australia [6] - The company also holds a 100% interest in the Porcupine Miracle Gold Prospect, consisting of 4 mineral claims in Ontario [7] - The company is actively evaluating additional opportunities [7]

Core Viewpoint - Fairchild Gold Corp. announces a non-brokered private placement financing expected to close around October 17, 2025, primarily backed by a European Strategic Investor [1][4]. Financing Details - The Offering will consist of up to 12,222,222 units priced at C$0.09 per unit, aiming for total gross proceeds of approximately C$1,100,000 [2]. - Each unit includes one common share and one common share purchase warrant, with the warrant allowing the purchase of an additional share at $0.15 for five years [2]. - An acceleration clause is included, allowing the company to expedite the expiry of warrants if the share price exceeds $0.50 for five consecutive trading days after 12 months from the closing date [2]. Regulatory and Use of Proceeds - The Offering is subject to necessary regulatory approvals, including from the TSX Venture Exchange, and securities will have a hold period of four months and one day post-closing [3]. - Proceeds will be utilized to advance the Company's Nevada gold projects and for general working capital [3]. Company Overview - Fairchild Gold Corp. focuses on acquiring, exploring, and developing high-quality mineral properties, with its flagship project being the Nevada Titan Project [5]. - The company also owns the Fairchild Lake Property, comprising 108 mining claims over 2,224 hectares in Ontario [5].

Core Points - Intrepid Metals Corp. has increased its private placement financing to $6.7 million due to strong investor demand, offering up to 19,142,858 units at a price of $0.35 per unit [1][2] - Each unit consists of one common share and one-half of a common share purchase warrant, with full warrants allowing the purchase of additional shares at $0.50 for 24 months [1][2] - The net proceeds will be allocated for exploration expenditures, working capital, property payments, and facilitating a strategic partnership transaction [2] Company Overview - Intrepid Metals Corp. is focused on exploring high-grade essential metals such as copper, silver, and zinc in southeastern Arizona, USA [5] - The company has several drill-ready projects, including the Corral Copper Project and the Tombstone South Project, both located in Cochise County, Arizona [5] - Intrepid is traded on the TSX Venture Exchange under the symbol "INTR" and on the OTCQB Venture Market under "IMTCF" [5]

Group 1 - Oracle Commodity Holding Corp. is a mining royalty company that has increased its non-brokered private placement financing from 7.5 million units to 8 million units due to high demand, raising potential gross proceeds to $280,000 [1][6] - Company insiders are set to subscribe for up to 1.75 million units, contributing up to $61,250, and this transaction is considered a related party transaction but the company is exempt from formal valuation and minority shareholder approval requirements [2][6] - The proceeds from the financing will be used for general corporate purposes and to acquire a 2% royalty from U.S. Fluorspar LLC over certain fluorspar projects, aiming to strengthen the company's position in the mining royalty sector [3][6] Group 2 - Oracle Corporation, a separate entity from Oracle Commodity Holding Corp., has maintained an "Outperform" grade from Evercore ISI, with a stock price of $296.96 and a raised price target from $340 to $350 [4] - Oracle has demonstrated an asset turnover ratio of approximately 0.33 over the trailing twelve months and an operating profit margin of about 30.44%, with a recent revenue report of $14.93 billion and a gross profit of $10.04 billion [5]

Core Viewpoint - Quoin Pharmaceuticals Ltd. has entered into a securities purchase agreement to potentially raise up to $104.5 million through PIPE financing, aimed at supporting its clinical development and general corporate purposes [1][6]. Financing Details - The financing includes participation from several healthcare-focused institutional investors such as AIGH Capital Management, Soleus Capital, and others [1][2]. - The private placement is priced at a premium to the previous day's closing stock price, with an initial upfront funding of $16.5 million and up to an additional $88.0 million from the exercise of accompanying warrants [1][3]. Securities Issuance - Quoin will issue a total of 1,993,940 American Depository Shares (ADSs) and warrants to purchase up to 7,975,760 ADSs at a combined purchase price of $8.25 per ADS and accompanying warrants [3][4]. - Certain investors are opting for pre-funded warrants at a slightly lower price of $8.2499 per warrant [4]. Warrant Structure - The accompanying warrants consist of four tranches, each with specific exercise prices and expiration conditions related to the FDA's approval process for QRX003, a treatment for Netherton Syndrome [5]. - Series H warrants have an exercise price of $9.075, Series I at $10.3125, and Series J and K at $12.375, with aggregate exercise prices of up to $18.1 million, $20.6 million, and $49.4 million respectively [5]. Use of Proceeds - The net proceeds from the private placement will be used for general corporate purposes, including operating expenses, research and development, and completion of clinical development for QRX003 [6]. Company Overview - Quoin Pharmaceuticals Ltd. is focused on developing therapeutic products for rare and orphan diseases, with a pipeline that includes treatments for conditions such as Netherton Syndrome and others [9].